Optune plus transducers
Ended Awarded
- Contract number
- 36C25025F0915
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,583
Award facts
- Contract value 100% obligated
- $16,582.91 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $49,749 | |
| Funding Only Action | -$33,166 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a $16,582.91 firm fixed-price delivery order to Novocure Inc. on July 18, 2025, for Optune Plus transducers with an ultimate completion date of October 31, 2025. This delivery order is issued under Novocure's existing Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award contract that commenced November 1, 2022, and extends through October 31, 2027. The award carries no set-aside designation and is delivered to Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer, specializes in Tumor Treating Fields technology for treating solid tumor cancers, including glioblastoma and mesothelioma, with all products FDA-approved for medical use.
This delivery order supports the VA's mission to provide veteran patients access to innovative, non-invasive cancer treatment technologies. Novocure serves as the prime contractor on this award and consistently delivers its proprietary Optune medical devices, transducer arrays, and associated support services directly to VA medical centers nationwide through firm fixed-price purchase orders. The company has established itself as a critical provider of cutting-edge cancer therapy solutions across multiple Veterans Integrated Service Networks, enabling VA facilities to expand their oncology treatment capabilities for veteran populations. No subcontractors are involved in the delivery of this specialized medical technology.
Quick answers
Who was awarded contract 36C25025F0915?
36C25025F0915 was awarded to Novocure Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on July 18, 2025.
How much is contract 36C25025F0915 worth?
The government has obligated $16,583 on 36C25025F0915.
Is contract 36C25025F0915 an order under another contract?
Yes. 36C25025F0915 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C25025F0915 competed?
The extent of competition for 36C25025F0915 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award